Retina · 2016 · 20 citations · 32 references
MedicineObstetricsOphthalmologyMaternal-fetal MedicineOcular DiseaseOcular PharmacologyAngiogenesisEndothelial DysfunctionAngiogenic ModulationAnti-vegf Ocular TherapyIntravitreal Anti-vascular Endothelial Growth Factor TherapyVascular Endothelial Growth FactorVascular Endothelial Growth Factor InhibitorsVascular Endothelial Growth Factor Receptor SignalingVascular Endothelial Growth Factor ReceptorsVascular Endothelial Growth Factor Signaling
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida P. J. Rosenfeld received research support from Carl Zeiss Meditec, Inc, Acucela, Apellis, Genentech/Roche, GlaxoSmithKline, Neurotech, Ocata Therapeutics, and Tyrogenex. He is a consultant for Achillion, Acucela, Alcon, Cell Cure Neurosciences, Chengdu Kanghong Biotech, CoDa Therapeutics, Genentech/Roche, Healios K.K., MacRegen Inc, NGM Biopharmaceuticals, Ocata Therapeutics, Regeneron, Stealth, and Tyrogenex. Z. H. Peracha has no disclosures.
32
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine, Cong Qian, Lucinda J. England et al. · New England Journal of Medicine · 2004 · 3.6K citations · Full text
Circulating angiogenic factors and the risk of preeclampsia*
Obstetrics and Gynecology · 2004 · 2.6K citations
Medicine, Gynecology, Obstetrics +14